Developing new chemical tools for fast biological reactions
Research Supplement to Promote Diversity for Toolkit for Fast Multipurpose and Inducible Bioorthogonal Chemistry
['FUNDING_R01'] · UNIVERSITY OF DELAWARE · NIH-11172946
This study is working on new ways to make certain chemical reactions faster and better, which could help create improved treatments for patients, all while supporting the growth of a graduate student in the process.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF DELAWARE (nih funded) |
| Locations | 1 site (Newark, UNITED STATES) |
| Trial ID | NIH-11172946 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative chemical tools that enhance the speed and efficiency of bioorthogonal reactions, specifically using a method called Tetrazine Ligation. By improving these reactions, the research aims to facilitate their application in biological contexts, which could lead to advancements in therapeutic techniques. The project also emphasizes diversity in research by supporting the work of graduate student Ashley Sias and includes a structured mentoring plan to foster career development. Patients may benefit from the improved biological therapies that arise from these advancements.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals seeking innovative treatments that utilize advanced bioorthogonal chemistry.
Not a fit: Patients with conditions that do not involve biological therapies or bioorthogonal chemistry may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective biological therapies for various conditions.
How similar studies have performed: Other research has shown promise in the field of bioorthogonal chemistry, indicating that this approach has the potential for significant advancements.
Where this research is happening
Newark, UNITED STATES
- UNIVERSITY OF DELAWARE — Newark, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FOX, JOSEPH M — UNIVERSITY OF DELAWARE
- Study coordinator: FOX, JOSEPH M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.